SCHEMBL8974717

SCHEMBL8974717

CCCCCCCCNC(C)C(O)c1ccc2c(c1)CCN2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ LMNA P02545 4/20 0.52
▸ SLC6A2 P23975 3/20 0.52
▸ SLC6A4 P31645 3/20 0.52
▸ OPRM1 P35372 3/20 0.52
▸ HIF1A Q16665 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ CYP2D6 P10635 2/20 0.52
▸ ADRA1A P35348 2/20 0.52
▸ SLC6A3 Q01959 2/20 0.52
▸ ADRB3 P13945 2/20 0.52
▸ SIGMAR1 Q99720 2/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ XBP1 P17861 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ ABCB11 O95342 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974380 0.77 LMNA (0.52) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL8974621 0.75 LMNA (0.50) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL11096043 0.74 LMNA (0.72) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL8974769 0.73 LMNA (0.50) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL8644590 0.71 LMNA (0.68) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL27713482 0.71 LMNA (0.68) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL16784192 0.71 LMNA (0.68) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL18609212 0.71 ADRB3 (0.64) ALDH1A1LMNASLC6A2SLC6A4OPRM1
SCHEMBL11301127 0.71 LMNA (0.56) ALDH1A1LMNASLC6A2SLC6A4OPRM1
Hydrochloric Acid SCHEMBL4931174 0.70 LMNA (0.66) ALDH1A1LMNASLC6A2SLC6A4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 — — EP claimed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 — — EP claimed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 — — WO claimed
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 — — EP disclosed
US-5462965-A Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases GD SEARLE & CO. (US) 1995-10-31 — — US disclosed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 — — EP disclosed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 — — WO disclosed
US-4638070-A HYPOTENSIVE CONTINENTAL PHARMA (BE) 1987-01-20 — — US disclosed
Send feedback